Indonesia drug agency approves China’s Walvax mRNA vaccine for emergency use
By Syndicated ContentSep 29, 2022 | 10:02 AM
JAKARTA (Reuters) – Indonesia food and drugs agency (BPOM) said on Thursday it has approved for emergency use the mRNA COVID-19 vaccine developed by China’s Walvax Biotechnology.
(Reporting by Stanley Widianto; Writing by Martin Petty)